NCT04386499View on ClinicalTrials.gov

Biological Effects of Treatment With Resveratrol in ART Patients

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 10, 2019

Primary Completion Date

March 11, 2020

Study Completion Date

May 5, 2020

Conditions
Infertility, Female
Interventions
DIETARY_SUPPLEMENT

Resveratrol

mixture of trans-resveratrol 150 mg (REVIFAST), folic acid 400 mcg, vitamin D, vitamin B12 and vitamin B6

DIETARY_SUPPLEMENT

Folic acid

400 mcg of folic acid

Trial Locations (1)

06156

University of Perugia, Piazza Menghini 1, S. Andrea delle Fratte., Perugia

All Listed Sponsors
lead

University Of Perugia

OTHER

NCT04386499 - Biological Effects of Treatment With Resveratrol in ART Patients | Biotech Hunter | Biotech Hunter